Skip to content
Orlistat
Active ingredient: Orlistat

Orlistat

Quality products
24/7 Support
Fast delivery
Delivery from 4 days
Select pack Package Per unit Price

Free delivery on orders from $ 312.00, free express delivery from $ 468.00

Secure Payments
Track your order
Best price guarantee

By blocking gastrointestinal enzymes that digest fat, Orlistat reduces the amount of dietary fat absorbed during a meal. Its action stays mainly in the gut rather than working on appetite or the brain.

Overview

Orlistat is the active ingredient in a medicine from the anti-obesity agent category known as gastrointestinal lipase inhibitors. Its pharmacological role is based on reducing the digestion and absorption of dietary fat in the gut rather than acting on appetite or the brain.

Dosage and administration

Orlistat capsules are taken by mouth with meals that contain fat. Dosing differs between strengths and between users, so there is no single amount that suits everyone. The prescribed dose should be taken during the meal or within one hour after it.

If a meal is skipped or contains no fat, that scheduled capsule is generally omitted. Taking an extra capsule later does not compensate for a missed dose and increases the chance of bowel side effects without improving the effect.

  • Swallow the capsule whole with water.
  • Take it with a main meal that contains dietary fat.
  • Omit the dose after a skipped meal or a fat-free meal.
  • Do not double a later dose after forgetting one.
  • Keep daily meals lower in fat and distribute fat between meals.
  • Use a multivitamin containing vitamins A, D, E, and K at a separate time of day, as Orlistat can reduce absorption of fat-soluble vitamins.
Many clinicians suggest taking a multivitamin at bedtime, separated from Orlistat-containing meals. This timing reduces the chance that the capsule will interfere with vitamin absorption.

Formulation

Orlistat is the active ingredient in a gastrointestinal lipase inhibitor used for weight management. It reduces the digestion and absorption of dietary fat in the gut and is used with a reduced-calorie, lower-fat eating plan.

How it affects the body

Orlistat belongs to the anti-obesity agents known as gastrointestinal lipase inhibitors. Lipases are enzymes released in the stomach and small intestine that split triglycerides from food into smaller molecules that can be absorbed. Orlistat binds to these enzymes and prevents part of this fat digestion, so some dietary fat passes through the bowel instead of contributing calories.

Orlistat does not suppress hunger. This distinction matters when comparing it with medicines that act on appetite-regulating hormones or brain pathways. Its advantage is a local digestive mechanism. Its limitation is equally clear: it cannot block calories from sugary drinks, alcohol, refined carbohydrates, or foods with very little fat.

Enzymatic Inhibition of Gastrointestinal Lipases

The capsule acts in the digestive tract after swallowing. It inhibits gastric and pancreatic lipases before dietary fat can be absorbed in the small intestine. The unabsorbed fat is then eliminated in stool.

This mechanism explains both the intended weight-loss effect and the familiar digestive effects. Oily spotting, loose stool, urgency, and gas with discharge are pharmacological consequences of fat leaving the body. They are not signs that the capsule has damaged the bowel.

A practical point patients often learn quickly: an unusually greasy meal can lead to urgency hours later, sometimes when travelling or during a work shift. Planning meals before long drives and meetings can prevent awkward surprises.

Metabolic Impact on Serum Lipids and Cholesterol

Weight reduction can improve several metabolic markers. Orlistat may also reduce LDL cholesterol because less dietary cholesterol and fat are absorbed. The European Medicines Agency product information describes reductions in body weight and improvements in lipid measures when Orlistat is combined with dietary treatment [1].

The medicine does not replace treatment for high cholesterol, diabetes, or high blood pressure when those conditions require their own therapy. It can be part of a broader weight-management plan, yet the response varies. Some people see gradual progress; others need their treatment plan reassessed if weight is not changing meaningfully.

Therapeutic indications

It is used alongside a reduced-calorie, lower-fat eating plan by adults managing obesity or excess weight with related health risks.

Common mistakes

Several avoidable patterns make Orlistat harder to use.

  • Taking it after every meal, including meals without fat. A dose is not needed when there is no dietary fat to block.
  • Doubling a dose after a missed capsule. This does not restore the missed effect.
  • Eating one very high-fat meal after otherwise low-fat eating. This often triggers oily leakage, diarrhoea, and urgency.
  • Stopping a multivitamin without considering vitamins A, D, E, and K.
  • Taking levothyroxine at the same time as Orlistat.
  • Treating persistent severe pain or rectal bleeding as an expected bowel effect.
  • Expecting the medicine to offset large portions, alcohol calories, or sugar-sweetened beverages.

A food record can reveal patterns quickly. The most useful entries are meal timing, approximate fat content, capsule timing, and bowel symptoms. This is more informative than judging the treatment from one difficult day.

Reasons not to use it

Orlistat is contraindicated in chronic malabsorption syndrome or cholestasis. Avoid use after a serious hypersensitivity reaction to Orlistat. Pregnancy is also a contraindication to intentional weight-loss pharmacotherapy.

When this is not for you

These conditions already impair nutrient handling and can make further interference with fat absorption unsafe.

Medical assessment is also needed before use if you have chronic kidney disease, a history of calcium oxalate kidney stones, liver disease, pancreatitis, gallbladder disease, or an eating disorder.

Breastfeeding also requires individual clinical advice because reliable treatment decisions depend on the parent’s nutritional needs and medical circumstances.

Possible side effects

Digestive changes are the most common effects of Orlistat. They are usually most noticeable early in treatment or after meals high in fat. The Canadian product information for orlistat describes oily or fatty stool, gas with oily discharge, more frequent bowel movements, soft stool, urgency, and abdominal discomfort as expected adverse effects [2].

The most frequently reported effects include:

  • fatty or oily stool;
  • orange or brown oily spotting in underwear;
  • loose stool or diarrhoea;
  • abdominal cramping or stomach pain;
  • sudden need for a bowel movement;
  • flatulence with oily discharge.

These effects often improve when dietary fat is reduced. They can return after a rich meal, even after weeks of otherwise good tolerance. This relationship is useful feedback rather than a reason to compensate by avoiding all dietary fat; the goal is a balanced, lower-fat pattern.

Keep a spare set of underwear or a light pad available during the first weeks if bowel urgency worries you. This small preparation helps people stay consistent while learning which meals trigger symptoms.

Orlistat can reduce absorption of vitamins A, D, E, and K. Reduced vitamin K absorption matters most for people taking anticoagulants. Long-term use also warrants attention to nutrition, including adequate protein, fibre, and micronutrients.

Severe reactions are uncommon, yet they require prompt assessment. Stop using Orlistat and seek urgent medical care for symptoms of anaphylaxis, such as swelling of the face, lips, tongue, or throat; wheezing; widespread hives; or trouble breathing.

Severe, persistent upper abdominal pain that may spread to the back, especially with vomiting or fever, can signal acute pancreatitis. This needs immediate medical evaluation. Rectal bleeding, black stool, yellowing of the skin or eyes, dark urine, severe itching, or persistent nausea also require urgent assessment because they may indicate bleeding or a liver-related problem.

Kidney stones and kidney injury have been reported in susceptible people because intestinal fat malabsorption can raise oxalate absorption. People with chronic kidney disease (CKD) need individual clinical assessment before using Orlistat. Health Canada advises attention to serious symptoms and interaction risks in its prescribing information [3].

Do not dismiss ongoing severe abdominal pain as a routine digestive side effect. Oily stool can be expected; severe pain, fever, repeated vomiting, or blood are different symptoms and need urgent assessment.

Comparison

Orlistat is distinct from medicines that affect appetite or blood glucose regulation. Selection depends on medical history, digestive tolerance, other medicines, and treatment goals.

Treatment mechanism Main action Key practical difference
Orlistat lipase inhibition Reduces absorption of dietary fat in the gut Bowel effects rise when meals are high in fat
GLP-1 receptor agonism Increases fullness and slows stomach emptying Usually affects appetite and may cause nausea
Appetite-regulating central mechanisms Acts through brain signalling pathways May affect mood, sleep, heart rate, or blood pressure depending on the medicine

Semaglutide, a GLP-1 receptor agonist, works through a very different pathway from Orlistat. It can reduce appetite and food intake, while Orlistat works only on fat digestion. Neither approach is universally preferable. Orlistat may suit someone who wants a non-appetite-based option, while frequent oily stool or urgency can make it a poor fit for someone with an unpredictable schedule.

What doctors say

In clinical practice, prescribers usually frame Orlistat as a behavioural support rather than a stand-alone answer to obesity. Its mechanism gives immediate feedback: high-fat meals often lead to more obvious bowel effects. For some people, that reinforces lower-fat choices; for others, the digestive burden is too disruptive.

Doctors also look beyond the scale. Waist measurement, blood pressure, glucose status, lipid levels, sleep apnea, joint pain, liver health, and medicines that promote weight gain can all influence the treatment plan. A modest but sustained reduction in weight can still improve health markers.

Orlistat has a clear advantage for people who prefer a treatment that does not act directly on the central nervous system. Its main drawback is tolerability. Someone who cannot reliably access a washroom after meals may find another strategy more workable.

Comparison

Alli

Active ingredient: Orlistat
60mg
From $ 223.08
pills
3.3 (3)

Contrave

Active ingredient: Bupropion
98mg
From $ 219.96
pills
3.8 (4)

Hoodia

Active ingredient: Hoodia
400mg60caps
From $ 124.80
bottles
3.6 (4)

Orlistat Current

Active ingredient: Orlistat
120mg 60mg
From $ 156.00
capsules
3.6 (4)

Comparison table: Weight Loss

Common questions

What is the best time of day to take Orlistat?

Take Orlistat with a main meal that contains fat, either during the meal or within one hour afterward. It does not need to be taken at a fixed clock time because its action is tied to food rather than to blood levels throughout the day. Health Canada product information, updated in 2024, advises omitting the dose when a meal is skipped or contains no fat [4]. A separate bedtime multivitamin is often practical because it creates distance from meal-time doses.

How long does one Orlistat dose keep working?

One dose works in the digestive tract around the meal with which it is taken. It blocks lipases while food and fat are being processed in the stomach and small intestine, rather than creating an all-day appetite effect. The European Medicines Agency described this local gastrointestinal action in its 2018 Orlistat product information. Bowel changes may appear later the same day or the following day, depending on meal timing and intestinal transit.

How does Orlistat differ from semaglutide?

Orlistat inhibits lipases and reduces dietary fat absorption, while semaglutide is a GLP-1 receptor agonist that affects appetite, fullness, stomach emptying, and glucose regulation. The World Health Organization’s 2024 obesity materials recognize that obesity care may include different medical approaches alongside nutrition and physical activity. Orlistat is associated mainly with oily stool and urgency, whereas GLP-1 receptor agonists commonly cause nausea, vomiting, or constipation. The two treatments have different suitability criteria and interaction profiles.

Can alcohol be used while taking Orlistat?

Alcohol does not have a direct lipase-blocking interaction with Orlistat. It can still add substantial calories, lower dietary restraint, and worsen dehydration if diarrhoea occurs. Health Canada’s 2024 product information emphasizes that treatment works with a reduced-calorie dietary plan, so alcohol can undermine weight-management goals even when it does not cause a direct drug interaction. Avoid alcohol if you have severe abdominal pain, vomiting, or signs of pancreatitis.

What happens when Orlistat is stopped, and does it need tapering?

Orlistat does not require tapering because it does not create physical dependence and has no withdrawal syndrome. Fat absorption returns toward its usual pattern after treatment stops, so oily stool and urgency generally settle as the medicine clears from the digestive tract. The EMA’s 2018 product information describes Orlistat as acting locally with minimal systemic absorption. Weight regain can occur if the lower-calorie, lower-fat eating pattern also stops, which is why sustainable routines matter after discontinuation.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Customer Feedback on Orlistat

3.6
Based on 4 reviews
Oliver N., 58 Nanaimo Nearly three months
Verified
Rating: 3.5 out of 5

I used Orlistat with lunch and dinner for nearly three months. The first week included oily stool after fish and chips, which was unpleasant but made the connection obvious. Once I changed to lighter meals, the urgency became much less frequent.

Nov 13, 2026
Liam F., 53 Saskatoon Two months
Verified
Rating: 3.5 out of 5

I had expected it to reduce hunger, but it did not work that way for me. I lost some weight over two months because I planned meals more carefully, although restaurant meals were stressful at first because I worried about needing a washroom.

Oct 15, 2026
Gary, 34 Saint John About three weeks
Verified
Rating: 3 out of 5

I stopped after about three weeks. The oily leakage happened twice after heavy meals, and that did not fit my work days. It was not painful, but it was inconvenient enough that I decided to discuss another option.

Oct 23, 2026
Thomas, 55 Barrie Four months
Verified
Rating: 4.5 out of 5

I took it consistently with meals containing fat for four months and used a vitamin in the evening. The routine was manageable after the first couple of weeks. I found that skipping fried foods mattered more than trying to make up for them later.

Oct 31, 2026

Sources

  1. European Medicines Agency (2018). Xenical: EPAR – Product information
  2. Health Canada (2024). Product Monograph: Orlistat
  3. Health Canada (2023). Orlistat: Health professional information
  4. Health Canada (2024). Consumer Information: Orlistat capsules
Get our free app Shop faster and track your orders 3.9 · 514 reviews Install